AIDS deaths in the U.S. are declining sharply as a direct result of powerful drug cocktails first introduced in early 1996, according to a provocative new research report. AIDS activists and researchers hailed the new report, published in the latest New England Journal of Medicine, an evidence that widening use of new protease drugs in combination with older AIDS medicines is creating an unexpectedly sharp turn of events in the 17 year fight against the deadly epidemic.